Hyaluronan synthesis is required for IL-2-mediated T cell proliferation

Journal of Immunology

Volumn 179, Issue 12, 2007, Pages 8191-8199

  Mahaffey, Christie L ^a   Mummert, Mark E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; HERMES ANTIGEN; HYALURONIC ACID; HYMECROMONE; INTERLEUKIN 2; IONOMYCIN; MITOGENIC AGENT; CYTOKINE; GLUCURONOSYLTRANSFERASE; HYALURONAN SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CARBOHYDRATE SYNTHESIS; CELL CULTURE; CELL DIVISION; CELL PROLIFERATION; CELLULAR IMMUNITY; CHEMICAL BINDING; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMUNOREACTIVITY; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ANIMALS; ANTIGENS, CD44; CELL PROLIFERATION; CYTOKINES; GLUCURONOSYLTRANSFERASE; HYALURONIC ACID; HYMECROMONE; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES;

EID: 40049111897     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.12.8191     Document Type: Article

References (44)

1. Nandi, A., P. Estess, and M. H. Siegelman. 2000. Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44. J. Biol. Chem. 275: 14939-14948.
2. Simpson, M. A., C. M. Wilson, L. T. Furcht, A. P. Spicer, T. R. Oegema, Jr., and J. B. McCarthy. 2002. Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells. J. Biol. Chem. 277: 10050-10057.
3. Itano, N., T. Sawai, M. Yoshida, P. Lenas, Y. Yamada, M. Imagawa, T. Shinomura, M. Hamaguchi, Y. Yoshida, Y. Ohnuki, et al. 1999. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J. Biol. Chem. 274: 25085-25092.
4. Sliwa, L. 1999. Hyaluronic acid and chemoattractant substance from follicular fluid: in vitro effect of human sperm migration. Arch. Androl. 43: 73-76.
5. Zhuo, L., M. Yoneda, M. Zhao, W. Yingsung, N. Yoshida, Y. Kitagawa, K. Kawamura, T. Suzuki, and K. Kimata. 2001. Defect in SHAP-hyaluronan complex causes severe female infertility: a study by inactivation of the bikunin gene in mice. J. Biol. Chem. 276: 7693-7696.
6. Camenisch, T. D., A. P. Spicer, T. Brehm-Gibson, J. Biesterfeldt, M. L. Augustine, A. Calabro, Jr., S. Kubalak, S. E. Klewer, and J. A. McDonald. 2000. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest. 106: 349-360.
7. Savani, R. C., C. Wang, B. Yang, S. Zhang, M. G. Kinsella, T. N. Wight, R. Stern, D. M. Nance, and E. A. Turley. 1995. Migration of bovine aortic smooth muscle cells after wounding injury: the role of hyaluronan and RHAMM. J. Clin. Invest. 95: 1158-1168.
8. Jameson, J. M., G. Cauvi, L. L. Sharp, D. A. Witherden, and W. L. Havran. 2005. γδ T cell-induced hyaluronan production by epithelial cells regulates inflammation. J. Exp. Med. 201: 1269-1279.
9. Deed, R., P. Rooney, P. Kumar, J. D. Norton, J. Smith, A. J. Freemont, and S. Kumar. 1997. Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells: inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int. J. Cancer 71: 251-256.
10. Savani, R. C., G. Cao, P. M. Pooler, A. Zaman, Z. Zhou, and H. M. DeLisser. 2001. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J. Biol. Chem. 276: 36770-36778.
11. Zhang, L., C. B. Underhill, and L. Chen. 1995. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res. 55: 428-433.
12. Mummert, M. E. 2005. Immunologic roles of hyaluronan. Immunol. Res. 31: 189-206.
13. Mummert, M. E., M. Mohamadzadeh, D. I. Mummert, N. Mizumoto, and A. Takashima. 2000. Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J. Exp. Med. 192: 769-779.
14. Siegelman, M. H., H. C. DeGrendele, and P. Estess. 1999. Activation and interaction of CD44 and hyaluronan in immunological systems. J. Leukocyte Biol. 66: 315-321.
15. Misra, S., B. P. Toole, and S. Ghatak. 2006. Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells. J. Biol. Chem. 281: 34936-34941.
16. Lesley, J., and R. Hyman. 1992. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur. J. Immunol. 22: 2719-2723.
17. Galandrini, R., E. Galluzzo, N. Albi, C. E. Grossi, and A. Velardi. 1994. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells. J. Immunol. 153: 21-31.
18. Mummert, M. E., D. Mummert, D. Edelbaum, F. Hui, H. Matsue, and A. Takashima. 2002. Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. J. Immunol. 169: 4322-4331.
19. Rudrabhatla, S. R., C. L. Mahaffey, and M. E. Mummert. 2006. Tumor microenvironment modulates hyaluronan expression: the lactate effect. J. Invest. Dermatol. 126: 1378-1387.
20. Mummert, D. I., A. Takashima, L. Ellinger, and M. E. Mummert. 2003. Involvement of hyaluronan in epidermal Langerhans cell maturation and migration in vivo. J. Dermatol. Sci. 33: 91-97.
21. Nakamura, T., K. Takagaki, S. Shibata, K. Tanaka, T. Higuchi, and M. Endo. 1995. Hyaluronic-acid-deficient extracellular matrix induced by addition of 4-methylumbelliferone to the medium of cultured human skin fibroblasts. Biochem. Biophys. Res. Commun. 208: 470-475.
22. Yoshihara, S., A. Kon, D. Kudo, H. Nakazawa, I. Kakizaki, M. Sasaki, M. Endo, and K. Takagaki. 2005. A hyaluronan synthase suppressor, 4-methylumbelliferone, inhibits liver metastasis of melanoma cells. FEBS Lett. 579: 2722-2726.
23. Rilla, K., S. Pasonen-Seppanen, J. Rieppo, M. Tammi, and R. Tammi. 2004. The hyaluronan synthesis inhibitor 4-methylumbelliferone prevents keratinocyte activation and epidermal hyperproliferation induced by epidermal growth factor. J. Invest. Dermatol. 123: 708-714.
24. Tanaka, Y., H. Ohdan, T. Onoe, and T. Asahara. 2004. Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine-secreting activity in T cells responding to allo-stimulation. Immunol. Invest. 33: 309-324.
25. Truneh, A., F. Albert, P. Golstein, and A. M. Schmitt-Verhulst. 1985. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 313: 318-320.
26. Mardiney, M., III, M. R. Brown, and T. A. Fleisher. 1996. Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen- or antigen-induced proliferative capacity in normals. Cytometry 26: 305-310.
27. Hughes-Fulford, M., E. Sugano, T. Schopper, C. F. Li, J. B. Boonyaratanakornkit, and A. Cogoli. 2005. Early immune response and regulation of IL-2 receptor subunits. Cell. Signal. 17: 1111-1124.
28. Kim, H. P., J. Imbert, and W. J. Leonard. 2006. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev. 17: 349-366.
29. Pimentel-Muinos, F. X., M. A. Munoz-Fernandez, and M. Fresno. 1994. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines. J. Immunol. 152: 5714-5722.
30. Chakrabarti, R., S. Kumar, and R. Chakrabarti. 1999. Relative roles of T-cell receptor ligands and interleukin-2 in driving T-cell proliferation. J. Cell. Biochem. 76: 37-43.
31. Nakamura, Y., S. M. Russell, S. A. Mess, M. Friedmann, M. Erdos, C. Francois, Y. Jacques, S. Adelstein, and W. J. Leonard. 1994. Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signalling. Nature 369: 330-333.
32. Nelson, B. H., J. D. Lord, and P. D. Greenberg. 1994. Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation. Nature 369: 333-336.
33. + T cells and is overcome by IL-2. Eur. J. Immunol. 32: 634-643.
34. DeGrendele, H., P. Estess, L. J. Picker, and M. H. Siegelman. 1996. CD44 and its ligand hayluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med. 183: 1119-1130.
35. DeGrendele, H., P. Estess, and M. H. Siegelman. 1997. Requirement for CD44 in activated T cell extravasation into inflammatory site. Science 278: 672-675.
36. McKallip, R. J., Y. Do, M. T. Fisher, J. L. Robertson, P. S. Nagarkatti, and M. Nagarkatti. 2002. Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens. Int. Immunol. 14: 1015-1026.
37. Ohno, S., H. J. Im, C. B. Knudson, and W. Knudson. 2005. Hyaluronan oligosaccharide-induced activation of transcription factors in bovine articular chondrocytes. Arthritis Rheum. 52: 800-809.
38. Ohno, S., H. J. Im, C. B. Knudson, and W. Knudson. 2006. Hyaluronan oligosaccharides induce matrix metalloproteinase 13 via transcriptional activation of NFκB and p38 MAP kinase in articular chondrocytes. J. Biol. Chem. 281: 17952-17960.
39. Lesley, J., N. Howes, A. Perschl, and R. Hyman. 1994. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J. Exp. Med. 180: 383-387.
40. Termeer, C. C., J. Hennies, U. Voith, T. Ahrens, J. M. Weiss, P. Prehm, and J. C. Simon. 2000. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J. Immunol. 165: 1863-1870.
41. Termeer, C., F. Benedix, J. Sleeman, C. Fieber, U. Voith, T. Ahrens, K. Miyake, M. Freudenberg, C. Galanos, and J. C. Simon. 2002. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195: 99-111.
42. Slevin, M., J. Krupinski, J. Gaffney, S. Matou, D. West, H. Delisser, R. C. Savani, and S. Kumar. 2007. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol. 26: 58-68.
43. Zaman, A., Z. Cui, J. P. Foley, H. Zhao, P. C. Grimm, H. M. DeLisser, and R. C. Savani. 2005. Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury. Am. J. Respir. Cell Mol. Biol. 33: 447-454.
44. Tolg, C., R. Poon, R. Fodde, E. A. Turley, and B. A. Alman. 2003. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor). Oncogene 22: 6873-6882.